Psilocybin Shows Promise in Treatment-Resistant Bipolar Type II Depression
Most patients achieved remission in small trial, and no hypomania episodes occurred
Stay updated with breaking news from Quick Inventory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Most patients achieved remission in small trial, and no hypomania episodes occurred
In the STAR*D study, NIMH investigators committed research fraud. The final outcomes paper needs to be retracted.
A new subtype of depression, the cognitive biotype, affects 27% of patients with depression who respond poorly to prescribed antidepressants.
The initial STAR*D study, which has been used to promote antidepressants, employed outcome switching to hide poor results.
A new subtype of depression, the cognitive biotype, affects 27% of patients with depression who respond poorly to prescribed antidepressants.